NCT01671592 Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI) Status COMPLETED Phase PHASE1
NCT01667198 Randomized Study of Train the Colonoscopy Leaders Course Versus Audit and Feedback on Colonoscopy Quality Indicators Status COMPLETED Phase NA
NCT01662752 Lymphatic Mapping for Sentinel Node Identification and Analysis Status COMPLETED Phase PHASE2
NCT01652482 Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC) Status COMPLETED Phase PHASE2
NCT01651624 Screening for Colorectal Cancer With FOBT, Virtual Colonoscopy and Optical Colonoscopy. A Randomized Clinical Trial in the Florence District Status COMPLETED Phase NA
NCT01641458 Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients Status COMPLETED Phase PHASE4
NCT01634126 Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening Status COMPLETED Phase EARLY_PHASE1
NCT01632722 Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver Mets Status COMPLETED Phase PHASE2
NCT01631539 Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC Status WITHDRAWN Phase NA
NCT01629524 Influence of Tumor Associated Immunity on the Number of Lymph Node Retrieved After Colorectal Cancer Surgery (Preliminary Study) Status COMPLETED Phase N/A
NCT01626963 Single-port Versus Conventional Laparoscopic Colorectal Surgery Status UNKNOWN Phase PHASE1/PHASE2
NCT01623206 Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding Status COMPLETED Phase PHASE2
NCT01622543 Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01613430 Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors Status COMPLETED Phase NA
NCT01610895 Split Dose Polyethylene Glycol (PEG) + Clear Fluids Versus Split Dose PEG + Low-Residue Diet Status UNKNOWN Phase NA